Loading data
AQSTNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 44.55 m USD | 57.56 m USD | 50.58 m USD | 47.68 m USD | 50.83 m USD |
| Cost of revenue | 18.56 m USD | 17.87 m USD | 20.83 m USD | 19.39 m USD | — |
| Research and development expense | 17.19 m USD | 20.28 m USD | 13.1 m USD | 17.48 m USD | 17.05 m USD |
| Selling, general and administrative expense | 79.85 m USD | 50.18 m USD | 31.75 m USD | 52.88 m USD | 53.48 m USD |
| Operating profit | -71.05 m USD | -30.77 m USD | -15.1 m USD | -42.07 m USD | -34.68 m USD |
| Interest expense | — | — | 6.34 m USD | 6.55 m USD | 10.05 m USD |
| Profit before tax | -83.78 m USD | -44.15 m USD | -7.63 m USD | -54.41 m USD | -70.54 m USD |
| Income tax expense | 0 USD | -14 k USD | 245 k USD | 0 USD | 0 USD |
| Net income (reported basis) | -83.78 m USD | -44.14 m USD | -7.87 m USD | -54.41 m USD | -70.54 m USD |
| Basic earnings per share | -0.78 USD/share | -0.51 USD/share | -0.13 USD/share | -1.12 USD/share | -1.85 USD/share |
| Diluted earnings per share | -0.78 USD/share | -0.51 USD/share | -0.13 USD/share | -1.12 USD/share | -1.85 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.